203 related articles for article (PubMed ID: 37030639)
21. Additive Manufacturing with 3D Printing: Progress from Bench to Bedside.
Rahman Z; Barakh Ali SF; Ozkan T; Charoo NA; Reddy IK; Khan MA
AAPS J; 2018 Sep; 20(6):101. PubMed ID: 30209693
[TBL] [Abstract][Full Text] [Related]
22. I Spy with My Little Eye: A Paediatric Visual Preferences Survey of 3D Printed Tablets.
Januskaite P; Xu X; Ranmal SR; Gaisford S; Basit AW; Tuleu C; Goyanes A
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33212847
[TBL] [Abstract][Full Text] [Related]
23. 3D-printing of solid lipid tablets from emulsion gels.
Johannesson J; Khan J; Hubert M; Teleki A; Bergström CAS
Int J Pharm; 2021 Mar; 597():120304. PubMed ID: 33540029
[TBL] [Abstract][Full Text] [Related]
24. 3D Printing Factors Important for the Fabrication of Polyvinylalcohol Filament-Based Tablets.
Tagami T; Fukushige K; Ogawa E; Hayashi N; Ozeki T
Biol Pharm Bull; 2017; 40(3):357-364. PubMed ID: 28250279
[TBL] [Abstract][Full Text] [Related]
25. 3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities.
Okafor-Muo OL; Hassanin H; Kayyali R; ElShaer A
J Pharm Sci; 2020 Dec; 109(12):3535-3550. PubMed ID: 32976900
[TBL] [Abstract][Full Text] [Related]
26. 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges.
Warsi MH; Yusuf M; Al Robaian M; Khan M; Muheem A; Khan S
Curr Pharm Des; 2018; 24(42):4949-4956. PubMed ID: 30520367
[TBL] [Abstract][Full Text] [Related]
27. Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing.
Zhang B; Nasereddin J; McDonagh T; von Zeppelin D; Gleadall A; Alqahtani F; Bibb R; Belton P; Qi S
Int J Pharm; 2021 Jul; 604():120626. PubMed ID: 33957266
[TBL] [Abstract][Full Text] [Related]
28. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
29. Pilot-scale binder jet 3D printing of sustained release solid dosage forms.
Tan M; Dharani D; Dong X; Maiorana C; Chaudhuri B; Nagapudi K; Chang SY; Ma AWK
Int J Pharm; 2023 Jan; 631():122540. PubMed ID: 36566828
[TBL] [Abstract][Full Text] [Related]
30. 3D Printing Technology in Drug Delivery: Recent Progress and Application.
Kotta S; Nair A; Alsabeelah N
Curr Pharm Des; 2018; 24(42):5039-5048. PubMed ID: 30520368
[TBL] [Abstract][Full Text] [Related]
31. Investigation of carbon footprint effect of renewable power plants regarding energy production: A case study of a city in Turkey.
Kerem A
J Air Waste Manag Assoc; 2022 Mar; 72(3):294-307. PubMed ID: 35030055
[TBL] [Abstract][Full Text] [Related]
32. Advances in powder bed fusion 3D printing in drug delivery and healthcare.
Awad A; Fina F; Goyanes A; Gaisford S; Basit AW
Adv Drug Deliv Rev; 2021 Jul; 174():406-424. PubMed ID: 33951489
[TBL] [Abstract][Full Text] [Related]
33. 3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges.
Desu PK; Maddiboyina B; Vanitha K; Rao Gudhanti SNK; Anusha R; Jhawat V
Curr Drug Targets; 2021; 22(16):1901-1914. PubMed ID: 33494666
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous fabrication of multiple tablets within seconds using tomographic volumetric 3D printing.
Rodríguez-Pombo L; Martínez-Castro L; Xu X; Ong JJ; Rial C; García DN; González-Santos A; Flores-González J; Alvarez-Lorenzo C; Basit AW; Goyanes A
Int J Pharm X; 2023 Dec; 5():100166. PubMed ID: 36880028
[TBL] [Abstract][Full Text] [Related]
35. Fused-filament 3D printing (3DP) for fabrication of tablets.
Goyanes A; Buanz AB; Basit AW; Gaisford S
Int J Pharm; 2014 Dec; 476(1-2):88-92. PubMed ID: 25275937
[TBL] [Abstract][Full Text] [Related]
36. Selective laser sintering additive manufacturing of dosage forms: Effect of powder formulation and process parameters on the physical properties of printed tablets.
Tikhomirov E; Åhlén M; Di Gallo N; Strømme M; Kipping T; Quodbach J; Lindh J
Int J Pharm; 2023 Mar; 635():122780. PubMed ID: 36849041
[TBL] [Abstract][Full Text] [Related]
37. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
[TBL] [Abstract][Full Text] [Related]
38. Additive Manufacturing of Solid Products for Oral Drug Delivery Using Binder Jetting Three-Dimensional Printing.
Wang Y; Müllertz A; Rantanen J
AAPS PharmSciTech; 2022 Jul; 23(6):196. PubMed ID: 35835970
[TBL] [Abstract][Full Text] [Related]
39. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.
Funk NL; Fantaus S; Beck RCR
Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751
[TBL] [Abstract][Full Text] [Related]
40. Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks.
Trenfield SJ; Xian Tan H; Awad A; Buanz A; Gaisford S; Basit AW; Goyanes A
Int J Pharm; 2019 Aug; 567():118443. PubMed ID: 31212052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
